Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan.

Authors:
Yoshiya Tanaka
Yoshiya Tanaka
University of Occupational and Environmental Health
Japan
Yoshinori Takahashi
Yoshinori Takahashi
Penn State University College of Medicine
Hershey | United States
Owen Hagino
Owen Hagino
Research and Development
Almont | United States
Neil M H Graham
Neil M H Graham
School of Life Sciences
Tempe | United States
Hideto Kameda
Hideto Kameda
Saitama Medical University
Japan

Arthritis Res Ther 2019 Apr 16;21(1):99. Epub 2019 Apr 16.

Division of Rheumatology, Department of Internal Medicine, School of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.

Following publication of the original article [1], the authors reported an error in Table 2.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1887-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469054PMC
April 2019
4 Reads

Publication Analysis

Top Keywords

iii trial
4
trial japan
4
phase iii
4
randomized placebo-controlled
4
response methotrexate
4
methotrexate randomized
4
japan publication
4
publication original
4
reported error
4
error table
4
authors reported
4
[1] authors
4
original article
4
article [1]
4
inadequate response
4
placebo-controlled phase
4
methotrexate patients
4
sarilumab methotrexate
4
rheumatoid arthritis
4
active rheumatoid
4

References

(Supplied by CrossRef)
Article in Arthritis Res Ther
Tanaka et al.
Arthritis Res Ther 2019

Similar Publications